The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions
about
A Blueprint for HIV Vaccine DiscoveryBroad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine targetNoninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody responseNeutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologyGlycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.Phages and HIV-1: from display to interplay.Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restrictionNew prospects for a preventive HIV-1 vaccine.HIV-host interactome revealed directly from infected cells.Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses.Humoral immunity in the Friend retrovirus infection model.Understanding and learning from the success of prophylactic human papillomavirus vaccines.Introduction of exogenous epitopes in the variable regions of the human immunodeficiency virus type 1 envelope glycoprotein: effect on viral infectivity and the neutralization phenotypeBroadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.
P2860
Q26829865-98D7F506-F180-4820-89C8-41DEEE9555B7Q29547347-70BA73E0-A38E-480E-88EC-5E799D482CF6Q31036522-E1990C37-014C-423E-A5DE-2A1CF25AAC1DQ33688229-C76C5E5B-5E1C-4A8F-96DD-E9CFC6C94D00Q33967039-A82342F8-7D00-4559-A1E0-2BD5BEB95644Q34034659-77F9FE9C-54AA-47A4-B124-3BB6201258BFQ34273397-C0052C12-24D1-4EC9-A3E1-F4DC26E2E472Q34624282-B26C6474-C884-41E0-BB8B-4822C54B5F33Q36223864-710C42F7-9094-4062-8FDC-F8C722828277Q37055800-940EF228-AEA5-43BD-A88F-213D22C2A015Q37143750-808395B6-AEDB-47B2-94D7-CD2001DA880CQ37730925-BADA37B2-E058-45C2-A121-F58B64C42892Q38041983-1C7530C8-0749-4DE7-B642-176548071BDBQ39843176-28CCAA7C-6F2A-4987-8DBB-AD8B603F1991Q40679052-43473093-7795-4180-9EE8-8201DD446F66
P2860
The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The human immunodeficiency vir ...... ody access to variable regions
@en
The human immunodeficiency vir ...... dy access to variable regions.
@nl
type
label
The human immunodeficiency vir ...... ody access to variable regions
@en
The human immunodeficiency vir ...... dy access to variable regions.
@nl
prefLabel
The human immunodeficiency vir ...... ody access to variable regions
@en
The human immunodeficiency vir ...... dy access to variable regions.
@nl
P2093
P2860
P356
P1433
P1476
The human immunodeficiency vir ...... ody access to variable regions
@en
P2093
Dennis R Burton
Ralph Pantophlet
Rowena O Aguilar-Sino
P2860
P304
P356
10.1128/JVI.02046-08
P407
P577
2008-11-26T00:00:00Z